The elderly population is likely to reach to 153.7 million
by FY’2025. This will lead to increase in demand for diagnosis and treatment
services for various health ailments such as chronic disorders in India.
The public healthcare expenditure in India is
expected to grow at a CAGR of 19.1% to a value of INR 700,570.8 crore in
FY’2025. This will lead to positive growth in sales volume of blood gas and
cardiac biomarker POC analyzer devices in the country.
Increase in penetration of medical insurance in the
country as a result of positive growth in the disposable income will aid in
increasing the penetration of healthcare facilities to remote areas. This will
lead to higher demand for these POC devices in the country.
Government Initiatives: Initiatives such as Ayushman
Bharat Yojana, Make in India and National Rural Health Mission aims at
extending healthcare facilities to remote regions. In the light of these
schemes, the blood gas and cardiac biomarker POC sector is expected to witness
rapid growth in sales volume as inpatient flow will increase which might
augment the number of medical procedures in the country leading to increase in
the revenue of the industry.
Rising Penetration of Insurance
and Growth in Medical Tourism: Rapid growth
in gross direct premium for medical insurance in the country will complement
the number of medical procedures conducted and consequentially higher revenue
for the POC industry. Easier medical visa approvals will lead to positive
influx of medical tourists in the country (size of the industry estimated to
reach USD 9.0 billion by 2020) which will complement the revenue of blood gas
and cardiac biomarker POC analyzer market.
Expanding Healthcare Infrastructure:
Increase
in number of secondary and tertiary hospitals (including private and government
with more than 50 beds estimated to reach 122,858 in FY’2025) will lead to
higher revenue realization as newer capital equipments with upgraded technology
will be installed in these hospitals. Also, the business of POC device
companies will be propelled by increase in number of patients with lifestyle
related diseases and cardiac disorders, in addition to rising demand for in-patient
care solutions.
Analysts at Ken
Research in their latest publication “India Blood Gas and Cardiac
Biomarker POC Analyzer Market Outlook to 2025- By Product (Device and Reagent),
By Device Type (Medium to High Workload and Single Test Analyzer Device), By
Region (Tier 1, Tier 2 and Tier 3) and By End User (Hospital, Clinics and Small
Health Setup and Diagnostic Labs)” observed that the market in India
is in growth stage and it will witness further growth owing to factors such as rising
healthcare expenditure, increase in number of healthcare establishments and increasing
penetration of medical insurance across the country. The blood gas POC analyzer
market is expected to register a positive CAGR of 17.2% while the cardiac
biomarker POC analyzer market is expected to register a positive CAGR of 19.3%
in terms of revenue during the forecast period FY’2019-FY’2025F.
Key Segments Covered:-
Blood Gas POC Analyzer Market:
By Type of Product (Reagent and Device)
By Type of Device (Medium to High Workload Device and
Single Test Analyzer Device)
By Region (Tier-1, Tier-2 and Tier-3)
By End User (Hospital, Clinics and Small Health Setup
and Diagnostic Lab)
Cardiac Biomarker POC Analyzer
Market:
By Type of Product (Reagent and Device)
By Type of Device (Semi-Automated Small Portable
System and Fully-Automated High End System)
By Type of Cardiac Biomarker (Troponin, CKMB,
NTproBNP, D-Dimer, CRP, Procalcitonin and Others)
By Region (Tier-1, Tier-2 and Tier-3)
By End User (Hospital, Clinics and Small Health Setup
and Diagnostic Lab)
Key Target Audience:-
Blood Gas Device Manufacturers
Blood Gas Reagent Manufacturers
Blood Gas Device Importers
Government Agencies
Cardiac Biomarker Analyzer Manufacturers
Cardiac Biomarker Reagent Manufacturers
Cardiac Biomarker Device Importers
Blood Gas and Cardiac Biomarker Analyzer Distributors
Time Period Captured in the
Report:-
Historical Period: FY’2014- FY’2019
Forecast Period: FY’2020F– FY’2025F
Companies
Covered:-
Blood Gas
POC Analyzer:
Radiometer
Siemens Healthcare
Instrumentation Laboratory
Abbott Healthcare
Roche Diagnostics
OPTI Medical System
Guangzhou Wondfo Biotech
Cardiac Biomarker POC Analyzer:-
Biomerieux
Quidel Diagnostics
Abbott Healthcare
Guangzhou Wondfo Biotech
Radiometer
Roche Diagnostics
Diasys Diagnostics
Boditec Med Inc
Agappe Diagnostics
Siemens Healthcare
Key Topics Covered in the Report:-
India Blood Gas and Cardiac Biomarker POC Analyzer
Market Overview
India Blood Gas and Cardiac Biomarker POC Analyzer Market
Size
India Blood Gas and Cardiac Biomarker POC Analyzer
Market Value Chain Analysis
India Blood Gas and Cardiac Biomarker POC Analyzer Market
Ecosystem
India Blood Gas and Cardiac Biomarker POC Analyzer Market
Segmentation
Government Role and Regulation in India Blood Gas and
Cardiac Biomarker POC Analyzer Market
Trends and Developments in Blood Gas and Cardiac
Biomarker POC Analyzer Market
Issues and Challenges in India Blood Gas and Cardiac
Biomarker POC Analyzer Market
Competitive Landscape in India Blood Gas and Cardiac
Biomarker POC Analyzer Market
Strength and Weakness of Major Players in India Blood
Gas and Cardiac Biomarker POC Analyzer Market
End User Perception in India Blood Gas and Cardiac
Biomarker POC Analyzer Market
SWOT Analysis India Blood Gas and Cardiac Biomarker
POC Analyzer Market
India Blood Gas and Cardiac Biomarker POC Analyzer
Market Future Projections, FY’2019-FY’2025F
Analyst Recommendations
For more information on the
research report, refer to below links:-
Related Reports:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
